# Long-term neuromuscular, cardiac and liver outcomes in an adult man affected with Chanarin-Dorfman syndrome

**Authors:** Kinza Noman, Andreas Tridimas, James B. Lilleker, Gaetano Nucifora, Peter Woolfson, Daniel du Plessis, Alison Woodall, Andrew Oldham, Mark E. Roberts, John Bassett, Federico Roncaroli, Simon A. Jones, Stefan Coassin, Florian Kronenberg, Karolina M. Stepien

PMC · DOI: 10.1016/j.ymgmr.2025.101265 · Molecular Genetics and Metabolism Reports · 2025-10-07

## TL;DR

This paper reports on a man with Chanarin-Dorfman syndrome and his long-term health outcomes, including muscle, heart, and liver issues, and the effectiveness of dietary and medical treatments.

## Contribution

The paper provides a detailed case study on long-term outcomes and management strategies for Chanarin-Dorfman syndrome in an adult.

## Key findings

- A low-fat diet, MCT oil, and co-enzyme Q10 improved muscle strength and stabilized symptoms.
- Lipid accumulation in muscle fibers may be a diagnostic feature of the syndrome.
- Regular cardiac MRI is important for monitoring the condition.

## Abstract

Chanarin-Dorfman syndrome (CDS) is an ultra-rare autosomal recessive subtype of neutral lipid storage disorder (NLSD); it is characterised by ichthyosis and intracytoplasmic accumulation of lipid droplets containing triglycerides, most commonly in granulocytes, muscle fibres, skin and liver. Several pathogenic variants in the ABHD5/CGI-58 gene have been described. Clinical manifestations include steatohepatitis, myopathy, ophthalmic disease, developmental delay. Liver involvement is an important cause of morbidity and mortality.

We present a case of a 26-year-old male diagnosed with ichthyotic NLSD in childhood, who developed progressive myopathy and cardiac fibrosis in adulthood. He was treated with a combination of low-fat diet, MCT oil and co-enzyme Q10 which resulted in an initial improvement in muscle strength and stabilisation of muscle symptoms and well-being.

Synopsis: Medical and dietetic management of liver and muscle complications in Chanarin-Dorfman syndrome.

•Marked vacuolation of neutrophils on blood film is consistent with Jordan's anomaly•Ichthyosis, raised creatine kinase, Jordan's anomaly and new onset myopathy are pathognomonic features of with Chanarin-Dorfman syndrome.•Lipid accumulation in type 1 and 2 fibres may be a diagnostic feature of the condition•The severity of the generalized ichthyosis is not correlated with the presence of lipid droplets in the epidermis•A low-fat diet, ursodeoxycholic acid and vitamin E can be recommended for patients with liver involvement.•Regular cardiac MRI is important for monitoring Chanarin-Dorfman syndrome.

Marked vacuolation of neutrophils on blood film is consistent with Jordan's anomaly

Ichthyosis, raised creatine kinase, Jordan's anomaly and new onset myopathy are pathognomonic features of with Chanarin-Dorfman syndrome.

Lipid accumulation in type 1 and 2 fibres may be a diagnostic feature of the condition

The severity of the generalized ichthyosis is not correlated with the presence of lipid droplets in the epidermis

A low-fat diet, ursodeoxycholic acid and vitamin E can be recommended for patients with liver involvement.

Regular cardiac MRI is important for monitoring Chanarin-Dorfman syndrome.

## Linked entities

- **Genes:** ABHD5 (abhydrolase domain containing 5, lysophosphatidic acid acyltransferase) [NCBI Gene 51099], ABHD5 (abhydrolase domain containing 5, lysophosphatidic acid acyltransferase) [NCBI Gene 51099]
- **Chemicals:** co-enzyme Q10 (PubChem CID 5281915), ursodeoxycholic acid (PubChem CID 31401), vitamin E (PubChem CID 14985)
- **Diseases:** Chanarin-Dorfman syndrome (MONDO:0010155), myopathy (MONDO:0005336), ichthyosis (MONDO:0019269)

## Full-text entities

- **Genes:** ABHD5 (abhydrolase domain containing 5, lysophosphatidic acid acyltransferase) [NCBI Gene 51099] {aka CGI58, IECN2, NCIE2}
- **Diseases:** myopathy (MESH:D009135), CDS (MESH:C536560), cardiac fibrosis (MESH:D005355), steatohepatitis (MESH:D005234), developmental delay (MESH:D002658), Liver involvement (MESH:D017093), liver and muscle complications (MESH:D008107), ophthalmic disease (MESH:C535922), ichthyosis (MESH:D007057)
- **Chemicals:** lipid (MESH:D008055), triglycerides (MESH:D014280), MCT oil (-)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12539267/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12539267/full.md

## References

40 references — full list in the complete paper: https://tomesphere.com/paper/PMC12539267/full.md

---
Source: https://tomesphere.com/paper/PMC12539267